蒂尔泽帕提德可降低肥胖相关心力衰竭的 LV 质量和心脂肪组织:SUMMIT CMR 亚体研究
Christopher M Kramer1, Barry A Borlaug2, Michael R Zile3
1Cardiovascular Division, Department of Medicine, University of Virginia Health, Charlottesville, Virginia, USA.
Journal of the American College of Cardiology
|November 20, 2024
概括
提尔泽帕提德显著减少了与肥胖相关的心力衰竭患者的左心室质量和心脏旁心脂肪组织,并保留了喷射分数 (HFpEF). 这些心脏改善与减肥相关,这表明减少心力衰竭事件的潜在机制.
科学领域:
- 心脏病学 心脏病学
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 肥胖是心力衰竭的重要危险因素,具有保存的喷射分数 (HFpEF),其特征是同心的左心室重塑.
- 心上脂肪组织 (EAT) 的增加在与肥胖相关的HFpEF中很常见,并且与不良的心血管结果有关.
研究的目的:
- 评估蒂尔泽帕提德对与肥胖相关的HFpEF患者心脏结构和功能的影响.
- 为了测试提尔泽帕提德在这个患者群体中减少左心室 (LV) 质量和心表脂肪组织 (EAT) 的假设.
主要方法:
- 在SUMMIT试验的心磁共振 (CMR) 副研究中,有175名患有与肥胖相关的HFpEF的患者.
- 106名患者在基线和52周完成了CMR,评估了LV质量,心房结构/功能和心脏准脂肪组织.
- 主要终点是LV质量的跨组变化.
主要成果:
- 与安慰剂相比,提尔泽帕提德治疗导致LV质量显著减少 (11g,P=0.004).
- 与提尔泽帕提德 (45毫升,P<0.001) 相比,心脏脂肪组织也显著减少.
- LV 质量的变化与体重,腰围和血压的减少相关.
结论:
- 在与肥胖相关的HFpEF中,提尔泽帕提德治疗有效降低了LV质量和心脏副类脂肪组织.
- 观察到的心脏结构变化与减肥有关.
- 这些发现表明,蒂尔泽帕提德可以改善心脏重塑,并有助于减少心力衰竭事件.
更多相关视频
07:38Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
3.4K
08:34Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy
Published on: September 25, 2017
24.3K
相关概念视频
01:29Cholesterol: Significance and Regulation
510
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
510
01:22Heart Failure Drugs: Diuretics
343
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
343